Ciencia y Tecnología para la Salud Visual y Ocular
Volume 20

Number 1

Article 3

2022-08-08

Dry Eye Syndrome, Corneal Perforation and Rheumatoid Arthritis:
About a Case
Fernando Godín Estrada
Universidad El Bosque, fgodin@unbosque.edu.co

Tito Gómez Quin
Universidad El Bosque, ojosdela93@hotmail.com

Diana Valeria Rey-Rodríguez
Universidad El Bosque, reydiana@unbosque.edu.co

María Angélica Chacón-Manosalva
Universidad Industrial de Santander, maria.angelica2909@hotmail.com

Follow this and additional works at: https://ciencia.lasalle.edu.co/svo

Citación recomendada
Godín Estrada F, Gómez Quin T, Rey-Rodríguez DV y Chacón-Manosalva MA. Dry Eye Syndrome, Corneal
Perforation and Rheumatoid Arthritis: About a Case. Cienc Tecnol Salud Vis Ocul. 2022;(1): 23-27. doi:
https://doi.org/10.19052/sv.vol20.iss1.3

This Artículo de investigación is brought to you for free and open access by the Revistas científicas at Ciencia
Unisalle. It has been accepted for inclusion in Ciencia y Tecnología para la Salud Visual y Ocular by an authorized
editor of Ciencia Unisalle. For more information, please contact ciencia@lasalle.edu.co.

https://doi.org/10.19052/sv.vol20.iss1.3

Dry Eye Syndrome, Corneal Perforation
and Rheumatoid Arthritis: About a Case *
Síndrome de ojo seco, perforación corneal y artritis reumatoidea:
a propósito de un caso
Fernando Godín Estrada**
Tito Gómez Quin***
Diana Valeria Rey-Rodríguez ****
María Angélica Chacón-Manosalva*****

Fecha de recepción: 4 de octubre de 2021. Fecha de aprobación: 12 de diciembre de 2021.
Publicación final: 1 de junio de 2022

ABSTRACT
The subject is a male patient with a history of rheumatoid arthritis, dry eye syndrome and corneal transplant 3 years ago. Patient reports decreased visual acuity in his right eye. On physical
examination, a rejection line is detected in meridian 6 of the cornea and temporal conjunctival
hyperemia. A month later, he reports increased pain, conjunctival hyperemia, excessive secretion
and visual acuity decreased to finger count at 3 meters in his right eye. The examination reveals
a 360º corneal vascularization and aseptic perforation of the central cornea. The first therapeutic
measure was cyanoacrylate and soft contact lenses, moxifloxacin 0.5% eye drops every 4 hours
and sodium hyaluronate 0.1% eye drops. Fifteen days later, he did not report improvement and
his visual acuity was reduced to finger count at 2 meters. On examination, neovascularization
in four quadrant and seidel test was positive. The next day a conjunctival graft was performed
improving the clinical condition; finally, a second tectonic corneal transplant was executed. The
therapeutic and surgical approach to a corneal perforation depends on the size, shape, location
and cause of the lesion, with cyanoacrylate tissue adhesives being useful in small lesions.
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RESUMEN
Se trata de un paciente masculino con antecedente de artritis reumatoidea, síndrome
de ojo seco y trasplante de córnea, hace 3 años. El paciente informa disminución de la
agudeza visual en el ojo derecho. En el examen físico, se detecta una línea de rechazo
en el meridiano a las 6 en la córnea e hiperemia conjuntival temporal. Un mes después
refiere secreción excesiva y disminución de la agudeza visual (cuenta dedos a 3 metros).
El examen reveló vascularización corneal de 360° y una perforación aséptica de la córnea
central. La primera medida terapéutica fue cianoacrilato y lentes de contacto blandos,
colirio de moxifloxacino al 0,5 % cada 4 horas, y colirio de hialuronato de sodio al 0,1 %.
Quince días después no refirió mejoría, y su agudeza visual se redujo a cuenta dedos a 2
metros. Al examen, la neovascularización en cuatro cuadrantes y la prueba Seidel fueron
positivas. Al día siguiente, se realizó un injerto conjuntival que mejoró el cuadro clínico;
finalmente, se realizó un segundo trasplante tectónico de córnea. El abordaje terapéutico
y quirúrgico de una perforación corneal depende del tamaño, forma, ubicación y causa
de la lesión, siendo útiles los adhesivos tisulares de cianoacrilato en lesiones pequeñas.

INTRODUCTION
Eye involvement represents a common finding
in patients with systemic autoimmune diseases.
Rheumatoid arthritis and their treatment often
affect the ocular surface and lead to reduced vision (1). Corneal condition that is derived may
be inflammatory, vascular or infectious, as well as
iatrogenic, in the case of corticosteroids, causes
that can lead to irreversible corneal (2). Corneal
transplant rejection has been reported from 2% to
50%, depending on the degree of vascularization
(2). The presence of dry eye syndrome has been
shown to increase the risk of corneal transplant
rejection. However, at least 30% of corneal transplant involvement shows episodes of immune
reaction and one third leads to graft failure (3).
The purpose of this study is to identify the interdisciplinary management, follow-up of rheumatoid
arthritis and the surgical approach after a corneal
complication, secondary to dry eye based on a
case report.
PRESENTATION OF THE CLINICAL
CASE
We describe herein the clinical course of a 69-yearold Colombian male doctor since the initial visit
to our institution. He presented foreign body
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sensation, tearing, burning and visual acuity
decrease in his right eye several weeks ago. No
symptoms were reported in the left eye. He had a
medical history of corneal transplant three years
ago for corneal opacity and dry eye syndrome. In
addition, the patient had diabetes mellitus, rheumatoid arthritis and hypothyroidism. The initial
best corrected visual acuity was 20/400 on the
right eye and 20/40 on the left eye. Additionally,
he presented a slight bilateral dysfunction of the
Meibomian gland. Line of rejection was observed
in meridian 6 in cornea, and temporal conjunctival hyperemia. The first diagnosis was corneal
transplant rejection and, consequently, prednisolone acetate 1% eye drops were prescribed. In
addition, rheumatology assessment was performed,
and rheumatoid factor, Anti-Sm, Anti-SS-A(Ro)
were analyzed, including a salivary gland biopsy
where the presence of amyloid in the labial salivary glands was reported. All tests were positive
and all doses were adjusted. A week later, the patient referred decreased of foreign body sensation,
tearing and burning, and improvement in visual
acuity. One month after the initial presentation,
the patient reported an increased pain, conjunctival hyperemia, excessive secretion and visual
acuity reduce to finger count at 3 meters on his
right eye. The left eye showed no discomfort. Slit
Lamp examination revealed 360º corneal vascularization and aseptic central corneal perforation.
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F igure 1. Vascularization in all quadrants and conjunctival
hyperemia

Source: own work

The poor response in his right eye suggested a second surgery, such as a tectonic corneal t ransplant,
since, as a result of his dry eye syndrome and the
immunologic response of rheumatoid arthritis,
he could undergo the conjunctival graft failure
at any time, and the threat could make a new
corneal perforation. The patient continued his

treatment with preservative free artificial tears,
carbomer eye gel, cyclosporine 0.1% eye drops and
interdisciplinary management with rheumatology and internal medicine. The corneal integrity
is stable, there is no new corneal perforations at
this moment, but its visual acuity unfortunately
decreased to light perception.
F igure 2. Negative Seidel Test
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The initial therapeutic management was prescribed
including cyanoacrylate and soft contact lens,
moxifloxacin 0.5% eye drops every 4 hours. The
dose of antibiotic was adjusted to the particular
case, taking into account the possible toxicity on
the epithelium; it was adjusted in the periodic
controls, sodium hyaluronate 0.1% eye drops preservative free every hour. Fifteen days later, the
patient reported signs of exacerbated pain in his
right eye, tearing, burning, abundant secretion,
and visual acuity decreased to finger count at 2
meters. He states using medication without any
improvement. The ophthalmological examination in the slit lamp revealed vascularization in
4 quadrants, conjunctival hyperemia (figure 1), a
central opacity with cyanoacrylate and centered
soft contact lens. Seidel test was positive. On the
next day, the patient was taken to be performed
a conjunctival graft in the right eye. At postoperative care, it was found a conjunctival coating
with suture in good condition (figure 2). Seidel
test was negative and declined symptoms in the
right eye, and the patient kept going with moxifloxacin 0.5% eye drops and sodium hyaluronate
0.1% eye drops preservative free.

Absence of communication between the anterior chamber of
the eye and the external surface
Source: own work

DISCUSSION
This case represents an interdisciplinary challenge
for managing combined pathologies such as dry
eye syndrome and rheumatoid arthritis, and, as a
consequence, for the decision on the best possible
treatment and continued care for the well-being
of the patient. As previously mentioned, the patient reported symptomatology in the transplanted eye from several weeks ago, involving corneal
transplant rejection, but those symptoms could
begin months earlier, being able to prevent the
worsening of the case. Rheumatoid arthritis is a
chronic autoimmune disease that affects many
organs, and has a prevalence of 0.8 to 1% of the
population (4). Ocular manifestations exist in
25% of patients with rheumatoid arthritis; in order of descending frequency, include keratoconjunctivitis sicca, corneal infection, episcleritis,
scleritis, anterior uveitis, or dissimilar variety of
corneal inflammation such as stromal keratitis,
peripheral ulcerative keratitis and sterile corneal
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ulceration (5). Villani et al. investigated corneal
commitment in rheumatoid arthritis with in vivo
confocal microscopy and found elevated quantity
of hyper reflective activated keratocytes, and then
suggested an inflammatory process in this autoimmune disease. Sterile corneal ulceration can
occur in either the central or peripheral cornea
with a deficiency of ocular symptoms, and may
lead to corneal perforation (6). Successful use of
tissue adhesive was reported in 6 of the 12 patients
with imminent or actual corneal perforation associated with rheumatoid arthritis, although the
use of tissue adhesive, is restricted to small perforation. The prognosis for graft survival in those
patients was poor as compared to the 95% survival
of grafts for the more common conditions, such
as Fuchs’ dystrophy, bullous keratopathy, and
keratoconus (6).
The most common cause of early failure of penetrating grafts was recurrent melt, which usually
involved the graft-host junction. This suggests that
aggressive management of this destructive process
in the perioperative period is essential. Currently,
systemic immunosuppression seems to be the best
way to achieve it. Ocular surface infection was
identified as the most important factor to influence
long-term graft survival after 6 months. Patients
with deficient corneal environment are known to
be at risk for microbial infections. Clear guidelines in the management of corneal perforation
in rheumatoid arthritis patients have not yet been
established. Data on the surgical management of
corneal perforations associated with rheumatoid
arthritis are scarce and mainly involve isolated
case reports or small series (6).

keratoplasty is valuable for maintaining ocular integrity, a transparency rate of only 67% has been
reported in cases with severe preoperative inflammation of the anterior segment (9).
The use of cyanoacrylate is used in perforations
measuring less than 3 mm in diameter, with a
concave profile and isolated from the limbus. In
some cases, its use can induce stromal, endothelial
and lenticular toxicity when it comes into contact
with the cornea or crystalline. Other complications
include increased intraocular pressure due to inflammation of the trabecular meshwork, microbial
keratitis, which is why third-generation antibiotics
are used in treatment as prophylactic agents (10).
The time going from the first cornea transplant, the
appearance of signs and the management of complications impacts on the visual prognosis. Ocular
signs could be a sensitive marker for identifying
the immune reactivation of rheumatic disease.
CONCLUSIONS
The therapeutic and surgical approach to a corneal
perforation depends on the size, shape, location
and cause of the lesion, with cyanoacrylate tissue
adhesives being useful in small lesions. The timely
diagnosis of eye diseases associated with chronic
pathologies such as rhetoid arthritis, can reduce
complications and sequelae at the ocular level.
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